Conference Coverage

10-year DCIS recurrence risk dwindles with age


 

References

“We don’t automatically recommend mastectomy under 40, but I think this data does make us very concerned about recurrence, and particularly invasive recurrence and its potential influence then on distant disease,” she said.

The study funding source was not reported. The authors reported having no disclosures. Dr. Tranakas reported no disclosures.

Pages

Recommended Reading

Breast cancer vaccines hold promise
MDedge Hematology and Oncology
VIDEO: Advice varies for chemoprevention, genetic testing in invasive breast cancer
MDedge Hematology and Oncology
VIDEO: Breast cancer surgery choice depends on the individual
MDedge Hematology and Oncology
Review: Use wider margins for DCIS surgery without radiotherapy
MDedge Hematology and Oncology
VIDEO: Counseling patients considering contralateral prophylactic mastectomy
MDedge Hematology and Oncology
VIDEO: Carefully consider impact of MRI to detect contralateral breast cancer
MDedge Hematology and Oncology
VIDEO: Weighing the cost-effectiveness of contralateral risk-reducing mastectomy
MDedge Hematology and Oncology
VIDEO: Treat most older women with stage I breast cancer with lumpectomy only
MDedge Hematology and Oncology
Exploratory analysis provides support for Recurrence Score
MDedge Hematology and Oncology
Breast density pegged as risk factor for contralateral cancer
MDedge Hematology and Oncology